openPR Logo
Press release

4th European Biopharma Congress

05-29-2017 07:22 PM CET | Health & Medicine

Press release from: Conference Series Ltd

Biopharma Conferences

Biopharma Conferences

Biopharmaceuticals Conference Series
Conference Series has been instrumental in conducting international Biopharmaceuticals meetings for several years, and very excited to expand Europe, America and Asia Pacific continents. Previous meetings were held in major cities like San Francisco, Baltimore, with success the meetings again scheduled in continents. 4th European Biopharma Congress, is scheduled to be held during November 09-11, 2017; at Vienna, Austria.

The opportunity in biopharmaceuticals is big and growing too rapidly to ignore. Today, biopharmaceuticals generate global revenues of $163 billion, making up about 20%of the pharma market. It’s by far the fastest-growing part of the industry: biopharma’s current annual growth rate of more than 8% is double that of conventional pharma, and growth is expected to continue at that rate for the foreseeable future.
The world of Big Pharma is not only growing, it's standing on its head. Worldwide spending for prescription branded drugs and generic medicines will jump 30% from 2013-2018 at compound annual growth rate of over 5% leading to a jaw-dropping $1.3 trillion in annual global drug sales. The market is also radically shifting position, with traditional strongholds, such as Japan and Europe, flipping over, and emerging markets, such as China, becoming the head

"Major proponents of business- or image-based definitions refuse to recognize biopharmaceuticals as a subset of pharmaceuticals, preferring to lump together and use the term to apply to all pharmaceuticals, associated R&D, companies and industry" says Ronald A Rader from nature biotechnology, Nature Publishing Group
I hope this message finds you well. I'm honored to request your participation as a speaker/delegate at “4th European Biopharma Congress” during November 9-11, 2017 at Vienna, Austria. Euro Biopharma 2017 is a three day event with an audience from various areas of Pharma and Biopharma assembling experts from Academy and Research-Professors, Assistant Professors, PhD Scholars, Pharmaceutical Associations and Societies, Pharmaceutical Business Entrepreneurs, Pharmaceutical Manufacturing Companies, Medical Devices Manufacturing Companies, Directors, CEO’s of Organizations, CROs and Clinical Data Management Companies.

Our aim is to bring together bright minds to give talks that are idea-focused, and on a wide range of subjects, to foster learning, inspiration and provoke conversations that matter.

Website: Biopharma Conferences

Benefits of speaker:

• Keynote sessions by world’s most eminent researchers.
• Networking with Experts in the field
• Being a part of global forum of Biopharma professionals
• Upon acceptance the abstract will receive DOI from CrossRef and published in conference proceedings book.
• Top Industry Representation by mostly C-level executives

We also encourage your colleagues and you to come in a group to the conference and avail the best possible discounts on Registration and accommodation.

We believe your voice would be a critical addition to the Euro Biopharma 2017 stage.
Thank you for reading, and we look forward towards receiving your participation confirmation at the earliest convenience.

Conference Series has been instrumental in conducting international Biopharmaceuticals meetings for several years, and very excited to expand Europe, America and Asia Pacific continents. Previous meetings were held in major cities like San Francisco, Baltimore, with success the meetings again scheduled in continents. 4th European Biopharma Congress, is scheduled to be held during November 09-11, 2017; at Vienna, Austria.

Chris Chappell
Program Manager | Euro Biopharma
Kemp House,
152 City Road,
London EC1V 2NX
Direct:+1-800-216-6499
Email:eurobiopharma@pharmaceuticalconferences.org

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release 4th European Biopharma Congress here

News-ID: 553752 • Views: 281

More Releases from Conference Series Ltd

4th International Conference on Hypertension & Healthcare
We take the privilege of hosting International Hypertension meetings worldwide and very excited to expand to 4th International Conference on Hypertension & Healthcare to be held in beautiful city Zurich, Switzerland in the month of September 10th- 11th, 2018. As with the three meetings, the Hypertension 2018 will be on high-level updates, debates, hot topics and future research directions in the areas of Cardiology, cardiovascular diseases, Pulmonary Hypertension, Hypertension &
20th European Cardiology Conference
Euro Cardiology 2017 invites all the cardiologists, Scientists, Professors, Research scholars, Industrial Professionals, Cardiac surgeons at 20th European Cardiology Conference is going to be held in Budapest, Hungary during October 16-18, 2017. With the support of Euro Cardiology 2016 Organizing Committee Members, the CME accredited 20th European Cardiology Conference is scheduled to be held in Budapest, Hungary during October 16-18, 2017. Cardiology Conferences will lay a platform for world-class professors, cardiologists
22nd World Cardiology Conference
World Cardiology 2017 22nd World Cardiology Conference December 11-12, Rome, Italy Accelerating Innovations & fostering advances in Cardio Research With the success of “16th World Cardiology Congress” in Dubai, World Cardiology Team is proud to host upcoming “22nd World Cardiology Conference” during December 11-12, 2017 Rome, Italy. The event will bring together world-class cardiologists, researchers and professors to discuss strategies for prevention of coronary disease, stroke and sudden death. World Cardiology Conference 2017

All 4 Releases


More Releases for Biopharma

Biopharma Outsourcing Market Analysis 2020 by Global Manufactures - Sartorius, E …
The Global Biopharma Outsourcing Market Research Report Forecast 2020-2025: The Biopharma Outsourcing Market report is a valuable source of insightful data for business strategists. It provides the industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). Report explores the current outlook in global and key regions from the perspective of players, countries, product types and end industries. The report provides in-depth analysis
Biopharma Outsourcing Market Future Analysis to 2023 |Sartorius, Emcure Pharmace …
According to the Biopharma Outsourcing Market report, the global market is expected to witness a relatively higher growth rate during the forecast period. This Biopharma Outsourcing Market Report cover strategic profiling of key players in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market. This study also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and
Biopharma Outsourcing Market to Witness Huge Growth By 2023 | Emcure Pharmaceuti …
HTF MI released a new market study on Global Biopharma Outsourcing Market with 100+ market data Tables, Pie Chat, Graphs & Figures spread through Pages and easy to understand detailed analysis. At present, the market is developing its presence. The Research report presents a complete assessment of the Market and contains a future trend, current growth factors, attentive opinions, facts, and industry validated market data. The research study provides estimates
Global Hereceptin Biosimilar Market Reports 2017- Mylan N.V., AryoGen Biopharma, …
The Hereceptin Biosimilar Market 2017 examines the performance of the Hereceptin Biosimilar market, enclosing an in-depth judgment of the Hereceptin Biosimilar market state and the competitive landscape globally. This report analyzes the potential of Hereceptin Biosimilar market in the present as well as the future prospects from various angles in detail. The Global Hereceptin Biosimilar Market 2017 report includes Hereceptin Biosimilar industry volume, market Share, market Trends, Hereceptin Biosimilar Growth aspects,
BioPharma Buffer Market 2017- Merck Millipore, Reliable Biopharma, Thermo Scient …
Apex Research, recently published a detailed market research study focused on the "BioPharma Buffer Market" across the global, regional and country level. The report provides 360° analysis of "BioPharma Buffer Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global BioPharma Buffer industry, and estimates the future trend of BioPharma Buffer market on
Arbutus Biopharma-Cancer Drugs Clinical Pipeline Insight
“Arbutus Biopharma-Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Arbutus. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline. Currently there are “6” cancer drugs in clinical pipeline and majority of them are in prclinical phase. There is 1 cancer drug by Arbutus Biopharma which is commercially available in the